BERLIN, Germany, June 19, 2018 /PRNewswire/ -- SAP SE (NYSE:
SAP) today announced Teva Pharmaceutical Industries Ltd. as the
2018 recipient of the Klaus Tschira Human Resources Innovation
Award and a €10,000 prize that Teva elected to donate to The END
Fund.
Teva is committed to providing access to affordable medicine
around the world. Over the years, the company underwent a series of
mergers, acquisitions and joint ventures, growing its workforce to
over 45,000 employees. To complement this growth, the company
embarked on a digital HR transformation journey and maintained a
strong talent management and succession planning program. With the
help of SAP® SuccessFactors® HCM Suite,
including the SAP SuccessFactors Employee Central solution, it was
able to:
- Turn HR into a strategic function with the support of
technology and metrics
- Simplify and harmonize HR processes globally using cloud
technology
- Replace 30 local HR solutions in 60 countries and consolidate
all core HR data into one system
- Improve talent acquisition, management, development and
retention
- Support its company vision to establish a people-focused
culture and way of working
- Provide managers with access to high-quality HR data relevant
to their responsibilities
- Create shared service centers for cost-effective service
delivery
- Achieve faster and more accurate reporting to the board and
business units
The Klaus Tschira HR Innovation Award, commissioned by SAP,
commemorates SAP cofounder Klaus Tschira and his vision for SAP to
revolutionize human resources to help organizations unleash the
full potential of their employees. It is awarded to a customer of
SAP SuccessFactors solutions that exemplifies a unique and
innovative solution in the field of HR.
"I'm delighted that the teams at Teva were selected to receive
this year's Klaus Tschira HR Innovation Award," said Greg Tomb, president, SAP SuccessFactors.
"Anat Markus will join me on stage
as a panelist in our keynote in Berlin and represent the teams in accepting
this award. Under her leadership guidance, the HR and HR IT teams
walked the talk of an integrated business strategy by working hand
in hand along their entire HR transformation journey. And at every
step, they put Teva's leaders and employees at the center of that
journey. It's impressive to see the commitment they have as an
industry leader in delivering affordable medication to people
around the world. Teva's selection of The END Fund as the recipient
of the Klaus Tschira HR Innovation Award charitable contribution
demonstrates that commitment. We're pleased to make this donation
in their name and expect it to have a meaningful impact on the work
of this organization."
"With our rapid growth across 60 countries around the world, we
needed a solution that would not only scale quickly but unify a
global workforce in a short amount of time," said Anat Markus, senior vice president, Global HR
Operations and Employee Services, Teva Pharmaceutical Industries
Ltd. "The SAP SuccessFactors solutions are helping us attract,
develop and enable the agile workforce of the future as we continue
to build a consumer-centric organization. We'd like to thank SAP
for its gracious €10,000 donation to The END Fund. Together, we can
help put an end to these parasitic and bacterial infectious
diseases and improve the lives of billions of people living in some
of the most vulnerable and poverty-stricken places across the
globe."
The END Fund is the only private philanthropic initiative
dedicated solely to ending the most common neglected tropical
diseases (NTDs), which affect more than 1.5 billion of the world's
most impoverished people, including 836 million children. The END
Fund engages a community of philanthropists, manages high-impact
strategic investments and works in collaboration with government,
NGO, pharmaceutical and academic partners to take a systems
approach to understanding, engaging with and influencing the broad
ecosystem of stakeholders working to end NTDs. The global
organization primarily works in African nations, as well as
Yemen, Afghanistan and India.
As part of its commitment, a Teva employee will join the "Summit
to See the END" that will engage dedicated visionaries,
humanitarians and entrepreneurs to join the hike of a lifetime,
while simultaneously raising awareness and funds to treat NTDs.
For more information, visit the SAP SuccessFactors Web site or
the SAP News Center. Follow SAP SuccessFactors solutions on Twitter
at @SuccessFactors and SAP at @sapnews.
About SAP
As market leader in enterprise application software, SAP (NYSE:
SAP) helps companies of all sizes and industries run better. From
back office to boardroom, warehouse to storefront, desktop to
mobile device – SAP empowers people and organizations to work
together more efficiently and use business insight more effectively
to stay ahead of the competition. SAP applications and services
enable more than 388,000 business and public sector customers to
operate profitably, adapt continuously, and grow sustainably. For
more information, visit www.sap.com.
Any statements contained in this document that are not
historical facts are forward-looking statements as defined in the
U.S. Private Securities Litigation Reform Act of 1995. Words such
as "anticipate," "believe," "estimate," "expect," "forecast,"
"intend," "may," "plan," "project," "predict," "should" and "will"
and similar expressions as they relate to SAP are intended to
identify such forward-looking statements. SAP undertakes no
obligation to publicly update or revise any forward-looking
statements. All forward-looking statements are subject to various
risks and uncertainties that could cause actual results to differ
materially from expectations. The factors that could affect SAP's
future financial results are discussed more fully in SAP's filings
with the U.S. Securities and Exchange Commission ("SEC"), including
SAP's most recent Annual Report on Form 20-F filed with the SEC.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of their dates.
© 2018 SAP SE. All rights reserved.
SAP and other SAP products and services mentioned herein as well
as their respective logos are trademarks or registered trademarks
of SAP SE in Germany and other
countries. Please see https://www.sap.com/copyright for additional
trademark information and notices.
For customers interested in learning more about SAP
products:
Global Customer Center: +49 180 534-34-24
United States Only: 1 (800) 872-1SAP (1-800-872-1727)
For more information, press only:
Geraldine Lim, SAP, +1 (415) 418-0945,
geraldine.lim@sap.com, PDT
SAP News Center press room; press@sap.com
Kate Lavoie-Mayer, PAN
Communications, +1 617-502-4338, klavoiemayer@pancomm.com, EDT
View original content with
multimedia:http://www.prnewswire.com/news-releases/teva-pharmaceuticals-honored-with-klaus-tschira-human-resources-innovation-award-300667833.html
SOURCE SAP SE